Searchable abstracts of presentations at key conferences in endocrinology

ea0020p199 | Endocrine tumours and neoplasia | ECE2009

The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumours

Plockinger Ursula , Kloppel Gunther , Lohmann Rudiger

Introduction: Clinical experience with neuroendocrine tumours (NET) is difficult to acquire because they are rare and heterogeneous. The impact of recently published guidelines on diagnosis and therapy of NET is not known. The German NET-Registry offers a unique possibility to analyse data on diagnostic/therapeutic performance in a wide range of institutions. This study posed three questions: who provides the care for patients with NET; do the diagnostic/therapeutic procedures...

ea0020p594 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Dose interval comparison of Lanreotide Autogel 120 mg in acromegalic patients previously treated with Octreotide LAR

Schopohl Jochen , Badenhoop Klaus , Beuschlein Felix , Droste Michael , Plockinger Ursula , Petersenn Stephan , Strasburger Christian

Acromegalic patients under treatment with Octreotide LAR (Oct), 10, 20 or 30 mg were switched to Lanreotide Autogel 120 mg (Lan) at different dose intervals: 56, 42 and 28 days respectively. Just before the fourth Lan injection, IGF-I values were measured and the dose interval for the final three injections adjusted accordingly: if IGF-I values were between 1 and 2 standard deviations (S.D.) above the age and sex related mean value, no change in dose-interval wa...

ea0041ep920 | Pituitary - Clinical | ECE2016

Fatigue and subjective complaints in patients with active and controlled acromegaly: a cross sectional multi-center study

Zimmermann Anca , Zwerenz Rudiger , Droste Michael , Schofl Christof , Strasburger Christian J , Plockinger Ursula , Honegger Jurgen , Millaku Bledar , Beutel Manfred E , Weber Matthias M

Introduction: Acromegalic patients (AP) often report fatigue and chronic subjective complaints. We aimed to investigate in more detail these aspects in AP, dependent on disease activity, age, gender, medication and pituitary insufficiency (PI).Patients/methods: Cross sectional, 124 patients (M/W 51/73, age 58.3±14.7 years, 49/75–active/controlled disease). The patients completed the Multidimensional Fatigue Inventory (MFI-20) and the Giessen Su...